Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: ENGAGE (Study 301) | Statement: [EMERGE (Study 302), relatedTrial, ENGAGE (Study 301)]

Target entity: ENGAGE (Study 301)
Context triple: [EMERGE (Study 302), relatedTrial, ENGAGE (Study 301)]

• A. ENGAGE (Study 301) chosen
  ENGAGE (Study 301) is a large Phase 3 clinical trial designed to evaluate the efficacy and safety of the anti-amyloid monoclonal antibody aducanumab (Aduhelm) in patients with early Alzheimer’s disease.
• B. EMERGE (Study 302)
  EMERGE (Study 302) is a pivotal Phase 3 clinical trial designed to evaluate the efficacy and safety of the Alzheimer’s disease drug aducanumab (Aduhelm) in patients with early-stage Alzheimer’s.
• C. APHINITY trial
  The APHINITY trial is a large phase III clinical study that evaluated the addition of pertuzumab (Perjeta) to standard trastuzumab-based adjuvant therapy in patients with HER2-positive early breast cancer.
• D. CLEOPATRA trial
  The CLEOPATRA trial was a pivotal phase III clinical study that demonstrated improved survival by adding pertuzumab (Perjeta) to trastuzumab and docetaxel in patients with HER2-positive metastatic breast cancer.
• E. ENSEMBLE trial
  The ENSEMBLE trial was a large, global Phase 3 clinical study designed to evaluate the safety and efficacy of Janssen’s single-dose COVID-19 vaccine in preventing SARS-CoV-2 infection and severe disease.
• F. None of above.
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Target predicate: relatedTrial
Context triple: [EMERGE (Study 302), relatedTrial, ENGAGE (Study 301)]

• A. trialAfter
  Indicates that one trial or legal proceeding occurs subsequent to another in time or sequence.
• B. relatedTest
  Indicates that there exists some form of connection or association between one test and another.
• C. trialName
  Indicates the designated name or title assigned to a specific trial.
• D. relatedCase
  Indicates that one legal case is connected or associated with another case, such as through shared facts, parties, issues, or procedural history.
• E. parallelExperiment
  Indicates that one experiment is conducted alongside another under comparable conditions, typically for simultaneous testing or comparison.
• F. None of above. chosen